source
- Experts warn FDA against approving Grail’s ineffective multicancer blood testPhysician and cancer‑screening researcher H. Gilbert Welch argues that the FDA should not greenlight Grail’s multicancer blood test, noting the company’s trial of 140,000 participants used a weak s…
- UK regulator adopts AI framework for medical devices and launches third AI Airlock phaseThe Medicines and Healthcare products Regulatory Agency (MHRA) announced that the UK government has adopted a set of recommendations on the use of artificial intelligence in medical devices. These…